Share

August 2015; 2 (4) ArticleOpen Access

Myopathy with anti-HMGCR antibodies

Perimysium and myofiber pathology

Ali Alshehri, Rati Choksi, Robert Bucelli, Alan Pestronk
First published June 4, 2015, DOI: https://doi.org/10.1212/NXI.0000000000000124
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
6013

Share

Article Information

vol. 2 no. 4 e124
DOI: 
https://doi.org/10.1212/NXI.0000000000000124
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • Received February 23, 2015
  • Accepted in final form May 1, 2015
  • First Published June 4, 2015.
Copyright & Usage: 
© 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Ali Alshehri, MD,
    2. Rati Choksi, MS,
    3. Robert Bucelli, MD, PhD and
    4. Alan Pestronk, MD
  1. Ali Alshehri, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Rati Choksi, MS,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Robert Bucelli, MD, PhD and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. 1) Parents of a family member I care for with Parsonage Turner syndrome, a financial gift was provided to me in hopes that it could be used towards Parsonage Turner research

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Alan Pestronk, MD
    5. Scientific Advisory Boards:

    1. Myositis Association, scientific advisory board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. (1) TS-HDS antibody 7,175,989, issued 2007; (2) GALOP antibody 6,121,004, issued 2000; (3) GM1 ganglioside antibody 6,077,681, issued 2000; (4) Sulfatide antibody 6,020,140, issued 1995

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Athena, speaker honoraria 2007-2009 The Myositis Association 2014-2015

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Genzyme, (2) Insmed, (3) Knopp, (4) Ultragenyx, (5) ISIS, (6) Sanofi, (7) Cytokinetics, (8) GSK, (9) Biogen, (10) CSL Behring

    Research Support, Government Entities:

    1. NIH

    Research Support, Academic Entities:

    1. Washington University Neuromuscular Research Fund

    Research Support, Foundations and Societies:

    1. (1) CINRG Children's Hospital Washington DC, Investigator 2007–2009; (2) Muscular Dystrophy Association, Investigator 2007-2009

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (A.A., R.C., R.B., A.P.) and Department of Pathology and Immunology (A.P.), Washington University School of Medicine, Saint Louis, MO.
  1. Correspondence to Dr. Pestronk: pestronka{at}neuro.wustl.edu
View Full Text

Article usage

Article usage: June 2015 to April 2023

AbstractFullPdfSource
Jun 201541817344Highwire
Jun 201502516pmc
Jul 20151692821Highwire
Jul 201507837pmc
Aug 20153143872Highwire
Aug 201505723pmc
Sep 2015754136Highwire
Sep 201506837pmc
Oct 2015474063Highwire
Oct 201508543pmc
Nov 2015327016Highwire
Nov 201507234pmc
Dec 2015355720Highwire
Dec 201507224pmc
Jan 2016238420Highwire
Jan 201606625pmc
Feb 2016329825Highwire
Feb 201605021pmc
Mar 20163811037Highwire
Mar 2016010124pmc
Apr 20161412530Highwire
Apr 201606719pmc
May 20163411238Highwire
May 201606023pmc
Jun 20162512538Highwire
Jun 201606215pmc
Jul 2016318021Highwire
Jul 201608615pmc
Aug 20162412734Highwire
Aug 2016010419pmc
Sep 20162111713Highwire
Sep 201608617pmc
Oct 20162014225Highwire
Oct 2016013920pmc
Nov 20162116715Highwire
Nov 2016015958pmc
Dec 20161915517Highwire
Dec 2016010114pmc
Jan 20171811913Highwire
Jan 2017015219pmc
Feb 20171412216Highwire
Feb 2017015214pmc
Mar 2017218815Highwire
Mar 2017024026pmc
Apr 20171610612Highwire
Apr 201722206237pmc
May 2017118611Highwire
May 201727262288pmc
Jun 201716606Highwire
Jun 201726228258pmc
Jul 20176363Highwire
Jul 201717283324pmc
Aug 201714369Highwire
Aug 201723322373pmc
Sep 201711386Highwire
Sep 201723268313pmc
Oct 20178415Highwire
Oct 201727340405pmc
Nov 201719419Highwire
Nov 201728347397pmc
Dec 20171685Highwire
Jan 201838212Highwire
Feb 201858612Highwire
Mar 20187732Highwire
Apr 201818113Highwire
Apr 201828365423pmc
May 2018014711Highwire
Jun 2018512411Highwire
Jun 201832374416pmc
Jul 201807610Highwire
Aug 20181685Highwire
Aug 201829370426pmc
Sep 201835012Highwire
Oct 201857112Highwire
Nov 20180834Highwire
Dec 201831827Highwire
Jan 201991275Highwire
Feb 20191013411Highwire
Mar 2019128416Highwire
Apr 2019104715Highwire
May 201945711Highwire
Jun 201947220Highwire
Jul 2019117217Highwire
Aug 201974020Highwire
Sep 20192448Highwire
Oct 20198843Highwire
Nov 20195579Highwire
Dec 201934617Highwire
Jan 202084714Highwire
Feb 202034110Highwire
Mar 202033510Highwire
Apr 202022115Highwire
May 20202389Highwire
Jun 20200279Highwire
Jul 20203267Highwire
Aug 20204489Highwire
Sep 202054816Highwire
Oct 20201679Highwire
Nov 202056723Highwire
Dec 202064713Highwire
Jan 202144013Highwire
Feb 202133913Highwire
Mar 202135214Highwire
Apr 202163513Highwire
May 202185512Highwire
Jun 20214559Highwire
Jul 202156019Highwire
Aug 20214759Highwire
Sep 20214779Highwire
Oct 202139142Highwire
Nov 202164624Highwire
Dec 202147215Highwire
Jan 202227124Highwire
Feb 202247419Highwire
Mar 202259317Highwire
Apr 202239613Highwire
May 202229014Highwire
Jun 2022310420Highwire
Jul 2022139515Highwire
Aug 20221014923Highwire
Sep 202279921Highwire
Oct 2022812422Highwire
Nov 2022714829Highwire
Dec 202259721Highwire
Jan 20231114622Highwire
Feb 2023516718Highwire
Mar 2023311012Highwire
Apr 20231010026Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me

Recommended articles